Leland Gershell

Stock Analyst at Oppenheimer

(1.96)
# 1424
Out of 5,218 analysts
144
Total ratings
47.37%
Success rate
26.82%
Average return
44 Stocks
Name Action Price Target Current % Upside Ratings Updated
argenx
Reiterates: Outperform
646 675
606.64 11.27% 5 Nov 21, 2024
Ascendis Pharma
Maintains: Outperform
190 180
130.25 38.2% 10 Nov 15, 2024
Dianthus Therapeutic...
Maintains: Outperform
48 52
23.76 118.86% 2 Nov 11, 2024
Ligand Pharmaceutica...
Maintains: Outperform
135 147
116.97 25.67% 2 Nov 8, 2024
Veru
Reiterates: Outperform
5 5
0.73 584.93% 8 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 73
46.59 56.69% 8 Oct 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
40 40
11.35 252.42% 9 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
47 53
26.32 101.37% 3 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 1 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 43
13.31 223.07% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 30
6.07 394.23% 2 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
12 12
4.03 197.77% 2 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
150 25
1.28 1853.12% 9 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
31 28
17.77 57.57% 5 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 25
5.73 336.3% 3 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 73
53.51 36.42% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 13
4.34 199.54% 5 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 20
2.78 619.42% 5 Jul 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
29 29
21.36 35.77% 3 Jun 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
35
9.22 279.61% 2 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 10
0.94 963.83% 1 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
5
3.27 52.91% 1 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 9
4.17 115.83% 2 Mar 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
23 20
1.83 992.9% 3 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 7 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 13
1.79 626.26% 3 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 4
0.64 525% 1 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Feb 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 1 Oct 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Aug 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
140
n/a n/a 1 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
36
n/a n/a 4 Dec 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
42
n/a n/a 1 Dec 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
n/a n/a 1 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
7200
0.35 2057042.86% 1 Jun 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 2 Mar 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
n/a
n/a n/a 2 Nov 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
3.23 1447.99% 1 Oct 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
4620 1470
3.74 39204.81% 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
225
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
112 115
n/a n/a 2 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
16 17
n/a n/a 2 May 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Perform
n/a
n/a n/a 4 Mar 31, 2020